retatrutide triple agonist glp-1 gip glucagon phase 2 obesity Mounjaro: and Diabetes The power of three: Retatrutide's
Description
Retatrutide metabolic benefits Retatrutide produces all of the metabolic benefits seen with Mounjaro plus additional improvements that appear unique to triple agonism: Blood sugar control: HbA1c reductions of 1.3% to 2.0% at doses of 4-12 mg in type 2 diabetes Blood pressure: Systolic blood pressure reduction of up to 14.0 mmHg at the highest dose (roughly double what Mounjaro achieves) Lipids: Non-HDL cholesterol and triglyceride reductions Prediabetes reversal: 72% of participants with prediabetes at baseline reverted to normoglycemia Inflammatory markers: Significant reductions in high-sensitivity C-reactive protein But the standout metabolic benefit, the one that has researchers most excited, is the effect on liver health
A slight foaming on the surface is normal if you swirled too vigorously
Our patients appreciate that we track real data with DEXA body composition scans, not just scale weight
My energy levels are better than theyve been in a decade
Symptoms are usually mild to moderate and are most common during the first weeks of treatment or after dose increases
